Neurolytic celiac plexus block for pancreatic cancer pain: A review of literature
The effective management of pancreatic cancer pain continues to be a major challenge for patients and clinicians. Up to 80% of patients with advanced pancreatic cancer present with the symptoms of severe pain. One of the most important goals in their management is achieving the highest quality of li...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2013-01-01
|
Series: | Indian Journal of Pain |
Subjects: | |
Online Access: | http://www.indianjpain.org/article.asp?issn=0970-5333;year=2013;volume=27;issue=3;spage=121;epage=131;aulast=Sehgal |
id |
doaj-ac5a6e0abccf40e684c4cd1e67fa4803 |
---|---|
record_format |
Article |
spelling |
doaj-ac5a6e0abccf40e684c4cd1e67fa48032020-11-24T22:36:42ZengWolters Kluwer Medknow PublicationsIndian Journal of Pain0970-53332013-01-0127312113110.4103/0970-5333.124584Neurolytic celiac plexus block for pancreatic cancer pain: A review of literatureSankalp SehgalAhmed GhalebThe effective management of pancreatic cancer pain continues to be a major challenge for patients and clinicians. Up to 80% of patients with advanced pancreatic cancer present with the symptoms of severe pain. One of the most important goals in their management is achieving the highest quality of life throughout the course of disease with effective palliation of pain. Majority of the current data supports the use Neurolytic celiac plexus block (NCPB) and has been shown to be more effective in reducing pain compared with standard pharmacotherapy. NCPBs have led to decreased opioid requirements and related side effects, thus preventing deterioration in quality of life. In this article, we discuss the treatment of pancreatic cancer pain and the advances in techniques of performing NCPB. We also analyzed the incidence of complications and the quality of pain relief with the use of NCPB. NCPB is effective, has a low incidence of complications, and should be used more often in patients with pancreatic cancer pain.http://www.indianjpain.org/article.asp?issn=0970-5333;year=2013;volume=27;issue=3;spage=121;epage=131;aulast=SehgalNeurolytic celiac plexus blockpancreatic cancerpain pathways in pancreatic cancer |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Sankalp Sehgal Ahmed Ghaleb |
spellingShingle |
Sankalp Sehgal Ahmed Ghaleb Neurolytic celiac plexus block for pancreatic cancer pain: A review of literature Indian Journal of Pain Neurolytic celiac plexus block pancreatic cancer pain pathways in pancreatic cancer |
author_facet |
Sankalp Sehgal Ahmed Ghaleb |
author_sort |
Sankalp Sehgal |
title |
Neurolytic celiac plexus block for pancreatic cancer pain: A review of literature |
title_short |
Neurolytic celiac plexus block for pancreatic cancer pain: A review of literature |
title_full |
Neurolytic celiac plexus block for pancreatic cancer pain: A review of literature |
title_fullStr |
Neurolytic celiac plexus block for pancreatic cancer pain: A review of literature |
title_full_unstemmed |
Neurolytic celiac plexus block for pancreatic cancer pain: A review of literature |
title_sort |
neurolytic celiac plexus block for pancreatic cancer pain: a review of literature |
publisher |
Wolters Kluwer Medknow Publications |
series |
Indian Journal of Pain |
issn |
0970-5333 |
publishDate |
2013-01-01 |
description |
The effective management of pancreatic cancer pain continues to be a major challenge for patients and clinicians. Up to 80% of patients with advanced pancreatic cancer present with the symptoms of severe pain. One of the most important goals in their management is achieving the highest quality of life throughout the course of disease with effective palliation of pain. Majority of the current data supports the use Neurolytic celiac plexus block (NCPB) and has been shown to be more effective in reducing pain compared with standard pharmacotherapy. NCPBs have led to decreased opioid requirements and related side effects, thus preventing deterioration in quality of life. In this article, we discuss the treatment of pancreatic cancer pain and the advances in techniques of performing NCPB. We also analyzed the incidence of complications and the quality of pain relief with the use of NCPB. NCPB is effective, has a low incidence of complications, and should be used more often in patients with pancreatic cancer pain. |
topic |
Neurolytic celiac plexus block pancreatic cancer pain pathways in pancreatic cancer |
url |
http://www.indianjpain.org/article.asp?issn=0970-5333;year=2013;volume=27;issue=3;spage=121;epage=131;aulast=Sehgal |
work_keys_str_mv |
AT sankalpsehgal neurolyticceliacplexusblockforpancreaticcancerpainareviewofliterature AT ahmedghaleb neurolyticceliacplexusblockforpancreaticcancerpainareviewofliterature |
_version_ |
1725718632598601728 |